Beur schreef op 28 februari 2014 10:28:
Uit de CC van Salix:
William Blair & Company L.L.C., Research Division.
"I guess, following up on RUCONEST. Are you prepared to launch the product yourself? I know it's a bit outside the GI or primary care focus and HIV is pretty competitive these days.
Carolyn J. Logan - Chief Executive Officer, President and Director.
it's a small number of physicians. So we certainly could do this ourselves, and we're looking very strongly at that. I don't know if we have 100% made that decision yet, but I think we are strongly leaning in that direction..."
Vaag antwoord van die CEO. Salix is er dus nog helemaal niet uit of ze Ruconest wel zelf aan de man willen gaan brengen...
ps "Rattentaal?", om met een gewaardeerd forumlid te spreken ;)